
Daan Gene Co., Ltd. — Investor Relations & Filings
Daan Gene Co., Ltd. specializes in the development and manufacturing of molecular diagnostic products and services. The company focuses on in vitro diagnostic technologies, particularly polymerase chain reaction (PCR) platforms. Its product portfolio includes diagnostic kits for infectious diseases, genetic screening, and oncology, alongside automated nucleic acid extraction systems and real-time PCR instruments. Daan Gene provides comprehensive solutions for clinical laboratories and public health institutions, integrating research, production, and clinical testing services. The organization emphasizes technological innovation in molecular biology to support precision medicine and disease control.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 广州达安基因股份有限公司2025年度营业收入扣除情况表的专项核查报告 | 2026-04-27 | Chinese | |
| 董事会审计委员会对会计师事务所2025年度履职情况评估及履职监督职责情况的报告 | 2026-04-27 | Chinese | |
| 广州达安基因股份有限公司2025年非经营性资金占用及其他关联资金往来的专项说明 | 2026-04-27 | Chinese | |
| 关于续聘致同会计师事务所(特殊普通合伙)为公司2026年度财务审计机构和内控审计机构的公告 | 2026-04-27 | Chinese | |
| 独立董事述职报告(裴新春) | 2026-04-27 | Chinese | |
| 关于举行2025年年度报告网上说明会的公告 | 2026-04-27 | Chinese |
Browse filings by year
23 years- 2026 38 filings
- 2025 128 filings
- 2024 93 filings
- 2023 73 filings
- 2022 157 filings
- 2021 134 filings
- 2020 120 filings
- 2019 94 filings
- 2018 116 filings
- 2017 110 filings
- 2016 132 filings
- 2015 172 filings
- 2014 167 filings
- 2013 95 filings
- 2012 64 filings
- 2011 57 filings
- 2010 72 filings
- 2009 66 filings
- 2008 63 filings
- 2007 84 filings
- 2006 55 filings
- 2005 78 filings
- 2004 21 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44391729 | 广州达安基因股份有限公司2025年度营业收入扣除情况表的专项核查报告 | 2026-04-27 | Chinese | ||
| 44391726 | 董事会审计委员会对会计师事务所2025年度履职情况评估及履职监督职责情况的报告 | 2026-04-27 | Chinese | ||
| 44391721 | 广州达安基因股份有限公司2025年非经营性资金占用及其他关联资金往来的专项说明 | 2026-04-27 | Chinese | ||
| 44391719 | 关于续聘致同会计师事务所(特殊普通合伙)为公司2026年度财务审计机构和内控审计机构的公告 | 2026-04-27 | Chinese | ||
| 44391718 | 独立董事述职报告(裴新春) | 2026-04-27 | Chinese | ||
| 44391716 | 关于举行2025年年度报告网上说明会的公告 | 2026-04-27 | Chinese | ||
| 44391713 | 2025年度利润分配公告 | 2026-04-27 | Chinese | ||
| 44391712 | 2025年年度报告 | 2026-04-27 | Chinese | ||
| 44391708 | 独立董事述职报告(范建兵) | 2026-04-27 | Chinese | ||
| 44391705 | 独立董事述职报告(侯向京) | 2026-04-27 | Chinese | ||
| 44391704 | 2025年度社会责任报告 | 2026-04-27 | Chinese | ||
| 44391702 | 关于2026年度日常关联交易预计的公告 | 2026-04-27 | Chinese | ||
| 44391699 | 公司章程(2026年4月) | 2026-04-27 | Chinese | ||
| 44391697 | 关于变更经营范围并修改《公司章程》的公告 | 2026-04-27 | Chinese | ||
| 44391695 | 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Daan Gene Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54093/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54093 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54093 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54093 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54093}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Daan Gene Co., Ltd. (id: 54093)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.